Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis.

× No keyword cloud information.

12 in total

1. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.

Authors: Heping Yang; Tony W H Li; Jian Peng; Xiaoli Tang; Kwang Suk Ko; Meng Xia; Maria-Angeles Aller
Journal: Gastroenterology Date: 2011-03-24 Impact factor: 22.682

2. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

Authors: Yunching Chen; Xiaodong Zhu; Xiaoju Zhang; Bin Liu; Leaf Huang
Journal: Mol Ther Date: 2010-07-06 Impact factor: 11.454

3. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.

Authors: Peter J Hurlin; Zi-Qiang Zhou; Kazuhito Toyo-oka; Sara Ota; William L Walker; Shinji Hirotsune; Anthony Wynshaw-Boris
Journal: EMBO J Date: 2003-09-15 Impact factor: 11.598

Review 4. The ups and downs of Myc biology.

Authors: Laura Soucek; Gerard I Evan
Journal: Curr Opin Genet Dev Date: 2009-12-03 Impact factor: 5.578

5. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation.

Authors: Tsung-Cheng Chang; Lauren R Zeitels; Hun-Way Hwang; Raghu R Chivukula; Erik A Wentzel; Michael Dews; Jason Jung; Ping Gao; Chi V Dang; Michael A Beer; Andrei Thomas-Tikhonenko; Joshua T Mendell
Journal: Proc Natl Acad Sci U S A Date: 2009-02-11 Impact factor: 11.205

6. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

Authors: N R Christoffersen; R Shalgi; L B Frankel; E Leucci; M Lees; M Klausen; Y Pilpel; F C Nielsen; M Oren; A H Lund
Journal: Cell Death Differ Date: 2009-08-21 Impact factor: 15.828

7. Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes.

Authors: Heping Yang; Tony W H Li; Kwang Suk Ko; Meng Xia; Shelly C Lu
Journal: Hepatology Date: 2009-03 Impact factor: 17.425

8. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.

Authors: Zhan Zhang; Hong Sun; Hongyue Dai; Ryan M Walsh; Maki Imakura; Janell Schelter; Julja Burchard; Xudong Dai; Aaron N Chang; Robert L Diaz; Joseph R Marszalek; Steven R Bartz; Michael Carleton; Michele A Cleary; Peter S Linsley; Carla Grandori
Journal: Cell Cycle Date: 2009-09-29 Impact factor: 4.534

9. A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.

Authors: Alphonse E Sirica; Zichen Zhang; Guan-Hua Lai; Toru Asano; Xue-Ning Shen; Deanna J Ward; Arvind Mahatme; Jennifer L Dewitt
Journal: Hepatology Date: 2008-04 Impact factor: 17.425

Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis.

1. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.

2. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

3. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.

Review 4. The ups and downs of Myc biology.

5. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation.

6. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

7. Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes.

8. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.

9. A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.

10. Mnt-Max to Myc-Max complex switching regulates cell cycle entry.

Review 1. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Review 2. Association of Exosomal miR-210 with Signaling Pathways Implicated in Lung Cancer.

Review 3. The role of hypoxia-induced miR-210 in cancer progression.

Review 4. c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.